Gernandt & Danielsson advised in Episurf Medical’s listing on NASDAQ OMX Stockholm

Episurf Medical’s application for listing of the company’s shares of series B on NASDAQ OMX Stockholm has been approved and the first day of trading in the shares is planned for 11 June 2014. The listing means that trading in Episurf Medical’s B-share is moved from NASDAQ OMX First North.

Episurf Medical aims at helping people with painful joints to lead more active lives by providing them with effective and individualized treatments. Episurf Medical’s individualized implants and surgical guides are developed for treatment of localized treatment of damaged cartilage in joints.

Gernandt & Danielsson has advised the company and its financial advisor Pareto Securities in the listing process, through a team which consisted of partner Carl Westerberg, senior associate Gustav Skogö and associate Oscar Anderson.